Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9926546 Engineered CRISPR-Cas9 nucleases

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
August 29, 2016
Date of Patent
March 27, 2018
Patent Application Number
15249756
Patent Citations Received
‌
US Patent 12110545 Methods of assessing nuclease cleavage
0
‌
US Patent 11920152 Increasing specificity for RNA-guided genome editing
0
‌
US Patent 12065668 RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci
0
‌
US Patent 11667911 Use of exonucleases to improve CRISPR/CAS-mediated genome editing
0
‌
US Patent 11680268 Methods for improving CRISPR/Cas-mediated genome-editing
0
‌
US Patent 11697826 Nucleic acid-guided nucleases
0
‌
US Patent 11866726 Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites
0
‌
US Patent 11911415 CRISPR/Cas-related methods and compositions for improving transplantation
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9926546
Patent Primary Examiner
‌
Karen Cochrane Carlson

Find more entities like US Patent 9926546 Engineered CRISPR-Cas9 nucleases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo